A Medical Technology That Has The Highest Potential Over Any We Follow.
You Must Read This...
New Report on the People Behind EMulate Therapeutics.
200 Million...
Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.
Hapbee Announces Additions to Advisory Board
December 17, 2020
New Advisors Bring Decades of Entrepreneurial ExperienceWellness...
Hapbee (HAPB): The Netflix of Feelings
After 15 years, $70 million spent on R&D, and 350,000+ hours of testing, this "Netflix of Feelings" wearable technology is finally...
BioSig (BSGM) Achieves First Commercial Sale of Three PURE EP Systems
Sale Marks Milestone for Company's Commercial expansion at leading Center of Excellence
Westport,...
Newsletter: Institutional Analyst. And Yes, We Have Another Double.
1. Dalrada (DFCO) $0.19. And Yes, We Have Another Double!2. Dyadic (DYAI) $6.40. We're Up 392%, Video Presentation.3....
Dalrada (DFCO) Finally Pops. Up 59% Today.
Up 59% today on news and with 4 million shares trading and counting!
LIVE QUOTE
Adding Hapbee (HAPB) to the Watch List.
Listed on TSX under HAPB, we're officially price and time stamping our interest in this amazing little technology Company by adding it...
Hapbee’s (HAPB) Device, “Choose How You Feel.”
HAPBEE ANNOUNCES LAUNCH OF A SUBSCRIPTION-BASED WELLBEING WEARABLE, PROVIDING MEMBERS THE ABILITY TO CHOOSE 'HOW THEY FEEL'
Proprietary, Research-Backed...
Aphex BioCleanse Systems Appoints Respected Marketing Veteran Mark Washo as Senior Vice President of...
PITTSFORD, N.Y., Nov. 12, 2020
PITTSFORD, N.Y. , Nov. 12, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization...
Hapbee (HAPB) Provides Update. Over 1,800 Devices Delivered.
Hapbee Provides Update on Recent Corporate Developments - Manufactured and Shipped Over 1,800 Hapbee Wearables to Early Adopters, Fulfilled All Orders from...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
